首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
BevacizumabThrombotic microangiopathy: 2 case reports
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2021年
/ 1838卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-021-89427-5
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:108 / 108
相关论文
共 50 条
[21]
GemcitabineThrombotic microangiopathy: 2 case reports
Reactions Weekly,
2015,
1553
(1)
: 157
-
157
[22]
CarfilzomibThrombotic microangiopathy: 2 case reports
Reactions Weekly,
2021,
1862
(1)
: 120
-
120
[23]
Immune globulinThrombotic microangiopathy: 2 case reports
Reactions Weekly,
2014,
1499
(1)
: 17
-
17
[24]
Multiple drugsThrombotic microangiopathy: 2 case reports
Reactions Weekly,
2022,
1897
(1)
: 272
-
272
[25]
GemcitabineNecrotic thrombotic microangiopathy: 2 case reports
Reactions Weekly,
2017,
1638
(1)
: 103
-
103
[26]
GemcitabineThrombotic microangiopathy of the kidneys: 2 case reports
Reactions Weekly,
2000,
790
(1)
: 7
-
8
[27]
CarfilzomibThrombotic-microangiopathy: 2 case reports
Reactions Weekly,
2024,
2032
(1)
: 117
-
117
[28]
Sirolimus/tacrolimusThrombotic microangiopathy: 2 case reports
Reactions Weekly,
2004,
998
(1)
: 16
-
16
[29]
Oxymorphone abuseThrombotic microangiopathy: 2 case reports
Reactions Weekly,
2023,
1956
(1)
: 417
-
417
[30]
DasatinibThrombotic microangiopathy and proteinuria: 2 case reports
Reactions Weekly,
2020,
1818
(1)
: 100
-
100
←
1
2
3
4
5
→